Saxenda Pens

Saxenda (liraglutide) is a popular injectable GLP-1 receptor agonist medication that is prescribed to help patients lose weight through delayed gastric emptying alongside appetite regulation. Thousands of patients across the U.S. trust Insulin Outlet for its easy online ordering and a large selection of name-brand diabetes medications at more affordable prices. Patients can use their valid prescriptions to order medications from licensed Canadian pharmacies that we partner with. We make sure that all patients receive authentic and carefully handled medication at a more accessible price point.

Saxenda is a medication that is used to support weight loss by acting on the brain to decrease appetite and make it easier for patients to reduce their food intake. It also makes patients feel full faster and can be an effective weight loss treatment. This prescription GLP-1 medication is a name brand for liraglutide. It can be used in adult patients considered to be obese (with a BMI ≥30) or adults who are considered to be overweight (with a BMI ≥27) with at least one weight-related comorbidity. It may also be used in some pediatric patients who are aged at least 12 years or older with a body weight of more than 60 kg with weight-related conditions.

• This is the first GLP-1 receptor agonist medication that has been approved by the FDA for use in weight loss
• Saxenda helps patients feel full faster and for longer periods of time
• This medication may also be prescribed for use in some pediatric patients (at least 12 years old and weighing over 60 kg)
• The name-brand medication is manufactured by a trusted medication brand (Novo Nordisk)

Saxenda comes in the form of an injectable pen medication that is to be taken on a daily basis. The patient’s doses of this medication are usually increased every week until the maximum dose of 3.0 mg is reached. The gradual escalation is intended to improve the patient’s tolerability of the medication. It is usually prescribed that patients start with a 0.6 mg titration dose for the first week. This dose is then usually increased to 1.2 mg the next week and then to 1.8 mg the following week. This dose may then be increased to 2.4 mg after an additional week. The final escalation after another week is to a dose of 3.0 mg – the amount of the maximum therapeutic dose. Body weight should be evaluated again after 16 weeks of treatment in adults (this may differ slightly in pediatric evaluation) and Saxenda should be stopped if the patient has not achieved at least a 4% reduction from their starting weight.

Saxenda should be taken once per day under the skin of the upper arm, stomach, or thigh. The pen for this medication may be used by:

1. Looking at the pen to make sure that the medication inside is clear/without color and that the label on the medication matches what was prescribed to the patient
2. Attaching a new needle to the device
3. Checking the flow of the pen (this should be done before the first injection is made from each new pen)
4. Selecting the correct dose of the pen
5. Making the injection of the dose in the proper injection site (the site should be rotated for each use) and counting to six
6. Removing the needle

The pens and the needles used for administering this medication should be properly stored or thrown away after their use. These items should never be shared between patients. This includes the pens – even if a new needle has been attached. Sharing pens/needles increases the risk of developing infections.

This medication comes with a boxed warning that has been issued by the FDA for the medication’s potential to cause C-cell tumors. This is an effect that was observed in studies done with rodents. The human risk is still unknown. The medication should not be taken by any patient who has previously been diagnosed with Medullary Thyroid Carcinoma for this reason. The same goes for any patients who have previously been diagnosed with Multiple Endocrine Neoplasia type 2 or who has had a family history with either of these issues.

Saxenda should also not be used by any patients who have a hypersensitivity to liraglutide or any of the other ingredients used in the making of the drug. Patients taking this medication should discontinue Saxenda right away if pancreatitis is suspected or if this condition has developed. Acute gallbladder disease may also occur in some patients taking this medication. Tests should be run by a doctor to check the patient’s gallbladder if they show symptoms that suggest cholelithiasis or cholecystitis.

Patients have a greater risk of developing hypoglycemia while taking this medication if they are also taking an insulin secretagogue or insulin medication at the same time. Patients using these medications together may require dose adjustments before starting Saxenda. However, the risk of developing hypoglycemia is low when Saxenda is used as a monotherapy. This medication can also lead to an increase in heart rate. Patients using this medication should have their heart rate monitored on a routine basis.

Postmarketing surveillance has shown some instances of patients experiencing renal impairment. This is usually a secondary effect that develops due to dehydration. Patients with kidney impairment should exercise additional caution when initiating or increasing doses of Saxenda. Anyone taking this medication with a history of depression or suicidal thoughts should be closely monitored.

This medication is also contraindicated in pregnant women and has the potential to lead to fetal harm. This medication is also not recommended for use in those who are breastfeeding since there is limited data to show the effects this would have on the baby. Doctors and healthcare providers should be made aware of any conditions the patient has or medications/supplements that the patient is taking before they start Saxenda.

Common Side Effects

Not every patient who is taking Saxenda will end up experiencing side effects. However, patients should still be informed about the most commonly reported ones. These include those such as:

• Diarrhea or nausea
• Enzyme level changes in the blood
• Vomiting or constipation
• Reactions at the site of the injection
• Stomach upset or pain
• Fatigue
• Headache
• Hypoglycemia (mainly a concern when used with insulin or insulin secretagogues such as sulfonylureas)

Teenagers who are taking this medication may also experience common side effects of fever or gastroenteritis – which are more rarely experienced by adults taking the medication. The list of side effects above is more likely to occur when a patient starts their medication or during dose increases. It is possible that the body will adjust and symptoms will resolve on their own over time. Patients should tell their doctors right away if they experience these side effects and they do not go away on their own or if they become severe.

Severe Side Effects

Some more serious side effects have occurred in less frequent cases. This includes possible effects such as:

• Kidney problems (this may occur from dehydration while taking this medication)
• Hypoglycemia (more commonly experienced by those who have type 2 diabetes and are combining this medication with other medications like sulfonylureas or insulin)
• Pancreatitis
• Increased heart rate
• Severe stomach issues
• Gallbladder issues
• Allergic reactions

Patients with a history of depression or suicidal thoughts should be closely monitored while on Saxenda. These issues may worsen while taking this medication.There may be an increased risk of aspiration during procedures that involve deep sedation or anesthesia in patients taking Saxenda. Patients should seek immediate medical attention if they experience any serious side effects.

Doses of Saxenda that have been missed should be skipped and the next dose should be taken at its regularly scheduled time the next day. Patients should never take an extra dose of the medication in place of the one that was missed – this includes dose increases to make up for the missed amount. A healthcare provider should be contacted if doses of this medication have been missed for three days or more. Patients who take too much of this medication should call their doctor or their local poison control/information center immediately.

Pens of Saxenda that have not been used yet should be stored in the refrigerator at temperatures between 36°F and 46°F (2°C to 8°C). Pens may either remain refrigerated or be kept at room temperature between 59°F and 86°F (15°C to 30°C) after first use. Pens must be discarded after 30 days once they have been started. This is the case even if there is still some medication remaining in the pen. Do not use the medication if it has been frozen or if the expiration date listed on the packaging has passed.

Patients buying their medications from Insulin Outlet experience:

• Possible savings of up to 80% on Saxenda compared to U.S. medication prices
• Real medication options from licensed Canadian pharmacies
• Flat $29.99 cold shipping
• Medications and services with a 4.9-star average rating from more than 4,000 users

Buy Saxenda from Canada today.

At Insulin Outlet, we ensure the safety and quality of our medications, meeting all federal legislation standards. Your order will be dispatched from a reputable licensed Canadian pharmacy, guaranteeing the highest standards of reliability and authenticity. This medication has been approved by Health Canada (Canada's FDA) and is identical to what you would receive in the US, only with Canadian labeling and packaging. We do not sell counterfeit or unauthorized medications. Our discounted medications are shipped directly from Canada to your doorstep, providing a fast and secure delivery experience. To conveniently buy Saxenda online at a significant discount, place your order above or call us at 1-888-238-0872.